{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:15:47Z","timestamp":1784690147563,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87624-1","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:19:09Z","timestamp":1741843149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of continuous venovenous hemodiafiltration in patients with metformin associated lactic acidosis and acute kidney injury"],"prefix":"10.1038","volume":"15","author":[{"given":"Emanuele","family":"De Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Marchisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Quattrocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Zoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Gervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"11","key":"87624_CR1","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies, M. J. et al. Management of hyperglycemia in type 2 diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 45(11), 2753\u20132786. https:\/\/doi.org\/10.2337\/dci22-0034 (2022).","journal-title":"Diabetes Care"},{"issue":"4","key":"87624_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40620-020-00941-8","volume":"34","author":"F Mariano","year":"2021","unstructured":"Mariano, F. & Biancone, L. Metformin, chronic nephropathy and lactic acidosis: A multi-faceted issue for the nephrologist. J. Nephrol. 34(4), 1127\u20131135. https:\/\/doi.org\/10.1007\/s40620-020-00941-8 (2021).","journal-title":"J. Nephrol."},{"issue":"10","key":"87624_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 15(10), 569\u2013589. https:\/\/doi.org\/10.1038\/s41574-019-0242-2 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"87624_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2215\/CJN.10871014","volume":"10","author":"LS Weisberg","year":"2015","unstructured":"Weisberg, L. S. Lactic acidosis in a patient with type 2 diabetes Mellitus. Clin. J. Am. Soc. Nephrol. 10(8), 1476\u20131483. https:\/\/doi.org\/10.2215\/CJN.10871014 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"87624_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2014.19","volume":"87","author":"JD Lalau","year":"2015","unstructured":"Lalau, J. D., Arnouts, P., Sharif, A. & De Broe, M. E. Metformin and other antidiabetic agents in renal failure patients. Kidney Int. 87(2), 308\u2013322. https:\/\/doi.org\/10.1038\/ki.2014.19 (2015).","journal-title":"Kidney Int."},{"issue":"1","key":"87624_CR6","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1002\/edm2.382","volume":"6","author":"N Van Moorter","year":"2023","unstructured":"Van Moorter, N., Tackaert, T., De Decker, K., Van Vlem, B. & De Neve, N. New potential for an old kid on the block: Impact of premorbid metformin use on lactate kinetics, kidney injury and mortality in sepsis and septic shock, an observational study. Endocrinol. Diabetes Metab. 6(1), e382. https:\/\/doi.org\/10.1002\/edm2.382 (2023).","journal-title":"Endocrinol. Diabetes Metab."},{"issue":"5","key":"87624_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjms.2022.01.026","volume":"364","author":"C-C Chen","year":"2022","unstructured":"Chen, C-C. et al. Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: the REMIND-TMU study. Am. J. Med. Sci. 364(5), 575\u2013582. https:\/\/doi.org\/10.1016\/j.amjms.2022.01.026 (2022).","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"87624_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s13181-020-00802-7","volume":"17","author":"SA Harding","year":"2021","unstructured":"Harding, S. A., Biary, R., Hoffman, R. S., Su, M. K. & Howland, M. A. A pharmacokinetic analysis of Hemodialysis for Metformin-Associated Lactic Acidosis. J. Med. Toxicol. 17(1), 70\u201374. https:\/\/doi.org\/10.1007\/s13181-020-00802-7 (2021).","journal-title":"J. Med. Toxicol."},{"key":"87624_CR9","unstructured":"EMA. Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function recommendations for patients with kidney impairment updated in product. ;44(October):0\u20133. (2016)."},{"issue":"7","key":"87624_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1159\/000518918","volume":"51","author":"L Van De Ginste","year":"2022","unstructured":"Van De Ginste, L. et al. Patients with severe lactic acidosis in the Intensive Care Unit: A retrospective study of contributing factors and impact of renal replacement therapy. Blood Purif. 51 (7), 577\u2013583. https:\/\/doi.org\/10.1159\/000518918 (2022).","journal-title":"Blood Purif."},{"issue":"8","key":"87624_CR11","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","volume":"43","author":"DP Calello","year":"2015","unstructured":"Calello, D. P. et al. Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit. Care Med. 43(8), 1716\u20131730. https:\/\/doi.org\/10.1097\/CCM.0000000000001002 (2015).","journal-title":"Crit. Care Med."},{"issue":"1","key":"87624_CR12","doi-asserted-by":"publisher","first-page":"e01561","DOI":"10.1213\/XAA.0000000000001561","volume":"16","author":"HV Reynolds","year":"2022","unstructured":"Reynolds, H. V., Pollock, H. H. G., Apte, Y. V. & Tabah, A. Achieving high Dialysis Dose via continuous renal replacement therapy in the setting of Metformin Associated Lactic Acidosis. A Case Series. A&A Pract. 16(1), e01561. https:\/\/doi.org\/10.1213\/XAA.0000000000001561 (2022).","journal-title":"A&A Pract."},{"issue":"3","key":"87624_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.clinthera.2006.03.004","volume":"28","author":"P Alivanis","year":"2006","unstructured":"Alivanis, P. et al. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin. Ther. 28(3), 396\u2013400. https:\/\/doi.org\/10.1016\/j.clinthera.2006.03.004 (2006).","journal-title":"Clin. Ther."},{"issue":"6","key":"87624_CR14","first-page":"285","volume":"27","author":"JD Lalau","year":"1989","unstructured":"Lalau, J. D. et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int. J. Clin. Pharmacol. Ther. Toxicol. 27(6), 285\u2013288 (1989).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"issue":"2","key":"87624_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1081\/clt-120004407","volume":"40","author":"F Barrueto","year":"2002","unstructured":"Barrueto, F., Meggs, W. J. & Barchman, M. J. Clearance of metformin by hemofiltration in overdose. J. Toxicol. Clin. Toxicol. 40(2), 177\u2013180. https:\/\/doi.org\/10.1081\/clt-120004407 (2002).","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"11","key":"87624_CR16","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/15563650.2022.2127363","volume":"60","author":"MS Correia","year":"2022","unstructured":"Correia, M. S. & Zane Horowitz, B. Continuous extracorporeal clearance in metformin-associated lactic acidosis and metformin-induced lactic acidosis: A systematic review. Clin. Toxicol. 60(11), 1266\u20131276. https:\/\/doi.org\/10.1080\/15563650.2022.2127363 (2022).","journal-title":"Clin. Toxicol."},{"issue":"2","key":"87624_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40620-018-00562-2","volume":"32","author":"P Greco","year":"2019","unstructured":"Greco, P. et al. Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury. J. Nephrol. 32(2), 297\u2013306. https:\/\/doi.org\/10.1007\/s40620-018-00562-2 (2019).","journal-title":"J. Nephrol."},{"issue":"4","key":"87624_CR18","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja, A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 120(4), c179\u2013c184 (2012).","journal-title":"Nephron Clin. Pract."},{"issue":"9","key":"87624_CR19","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov, D. et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with Regional Citrate Anticoagulation. Crit. Care Med. 45(9), e941\u2013e946. https:\/\/doi.org\/10.1097\/CCM.0000000000002501 (2017).","journal-title":"Crit. Care Med."},{"issue":"3","key":"87624_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/039139880703000310","volume":"30","author":"L Cubattoli","year":"2007","unstructured":"Cubattoli, L., Teruzzi, M., Cormio, M., Lampati, L. & Pesenti, A. Citrate anticoagulation during CVVH in high risk bleeding patients. Int. J. Artif. Organs. 30(3), 244\u2013252. https:\/\/doi.org\/10.1177\/039139880703000310 (2007).","journal-title":"Int. J. Artif. Organs"},{"issue":"3","key":"87624_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000471917","volume":"44","author":"F Mariano","year":"2017","unstructured":"Mariano, F. et al. Metformin-Associated Lactic Acidosis undergoing renal replacement therapy in Intensive Care units: A five-million Population-based study in the North-West of Italy. Blood Purif. 44(3), 198\u2013205. https:\/\/doi.org\/10.1159\/000471917 (2017).","journal-title":"Blood Purif."},{"issue":"8","key":"87624_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4239\/wjd.v13.i8.654","volume":"13","author":"D Juneja","year":"2022","unstructured":"Juneja, D., Nasa, P. & Jain, R. Metformin toxicity: A meta-summary of case reports. World J. Diabetes. 13(8), 654\u2013664. https:\/\/doi.org\/10.4239\/wjd.v13.i8.654 (2022).","journal-title":"World J. Diabetes"},{"issue":"2","key":"87624_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/15563650.2013.860985","volume":"52","author":"S Vecchio","year":"2014","unstructured":"Vecchio, S. et al. Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin. Toxicol. (Phila). 52(2), 129\u2013135. https:\/\/doi.org\/10.3109\/15563650.2013.860985 (2014).","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"4","key":"87624_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1476-5381.1992.tb09093.x","volume":"105","author":"CJ Bailey","year":"1992","unstructured":"Bailey, C. J., Wilcock, C. & Day, C. Effect of metformin on glucose metabolism in the splanchnic bed. Br. J. Pharmacol. 105(4), 1009\u20131013. https:\/\/doi.org\/10.1111\/j.1476-5381.1992.tb09093.x (1992).","journal-title":"Br. J. Pharmacol."},{"key":"87624_CR25","doi-asserted-by":"crossref","unstructured":"Bouchard, J. et al. Principles and operational parameters to optimize poison removal with extracorporeal treatments. In Seminars in Dialysis (Vol. 27, No. 4, pp. 371\u2013380). (2014), July.","DOI":"10.1111\/sdi.12247"},{"issue":"2","key":"87624_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1464-5491.2011.03474.x","volume":"29","author":"S Dichtwald","year":"2012","unstructured":"Dichtwald, S., Weinbroum, A. A., Sorkine, P., Ekstein, M. P. & Dahan, E. Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy. Diabet. Med. 29(2), 245\u2013250 (2012).","journal-title":"Diabet. Med."},{"issue":"9","key":"87624_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/aas.13659","volume":"64","author":"P Uusalo","year":"2020","unstructured":"Uusalo, P. & J\u00e4rvisalo, M. J. Mortality and renal prognosis in isolated metformin-associated lactic acidosis treated with continuous renal replacement therapy and citrate-calcium-anticoagulation. Acta Anaesthesiol. Scand. 64(9), 1305\u20131311. https:\/\/doi.org\/10.1111\/aas.13659 (2020).","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"11","key":"87624_CR28","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","volume":"19","author":"JD Lalau","year":"2017","unstructured":"Lalau, J. D. et al. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm. Diabetes Obes. Metab. 19(11), 1502\u20131512. https:\/\/doi.org\/10.1111\/dom.12974 (2017).","journal-title":"Diabetes Obes. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87624-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:19:14Z","timestamp":1741843154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87624-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87624"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87624-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. This audit study adhered to ethical guidelines outlined by ASL Citt\u00e0 di Torino (UNI EN ISO 9000:2000 and ISO 19011:2003 as dictated by the Italian Health Ministry Quality (REF), ensuring the protection of participants\u2019 confidentiality, voluntary participation, and compliance with ethical standards in data collection and analysis. All data were recorded as non-identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8636"}}